EVALUATION OF COMPLIANCE AND RESPONSE OF NAUSEA VOMITING antiemetic USE THE BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY IN Hospital PROF. DR. MARGONO Soekarjo

ABSTRACT: Breast cancer is one of the cancers with the highest incidence, especially in women. The development of therapy has been implemented to improve the survival and prognosis of breast cancer patients. Breast cancer treatment is given by considering many factors, including age, menopausal status, comorbidities, stage of cancer, biological factors and history of chemotherapy. Optimization of quality of life during treatment is very important. Chemotherapy Induced Nausea vomitting (CINV) is a common side effect and can affect the quality of life of cancer patients. The aims of this study are to know response of nausea vomitting, patients adherence, relationship between adherence and response of nausea vomitting. This study is an observational study conducted by descriptive and analytic study design in Prof. Dr. Margono Soekarjo hospital. The results of this study are the nausea and vomitting response are the most in the acute emesis phase (80%) and delayed emesis (90%). A total of 79% adherent and 21% poor adherent. There is no relationship between adherence and the response of nausea vomitting in Prof. Dr. Margono Soekarjo hospital.